Single step deployment system increases market
potential while reducing install times by 80%
Incorporates Enhanced ContraPest Formulation
for Improved Performance in the Field
PHOENIX, July 24,
2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES,
"SenesTech" or the "Company"), (www.senestech.com) the rodent
fertility control experts and inventors of the only EPA registered
contraceptive for male and female rats, announced the launch of a
new delivery system for ContraPest®, the Isolate Bait
System™. This system also incorporates an enhanced formulation of
ContraPest that is expected to provide improved performance of the
fertility control bait in the field. The Isolate is paired with a
new bait station that is more efficient and economical.
Product Overview: The Isolate Bait System is specifically
designed based on customer demands for a more efficient and
easier-to-use bait system.
- Quick and Easy Deployment
- With a simple peel-off seal, the Isolate Bait System allows for
rapid placement and setup, with users showing up to 80% reduction
in time and effort
- User-Friendly Design
- The integrated tank-tray unit is designed for ease of use,
catering to both professionals and the do-it-yourself market.
- Convenient Size
- With a compact 8 fl. oz. size, it is manageable and suitable
for all users, enhancing the overall experience, and is
- Increased Efficiency
- The new design, along with an enhanced formulation, ensures
improved performance in the field, providing superior results.
- Enhanced Servicing Experience
- By combining the tank and tray into one unit, this system
simplifies the servicing process, making maintenance quicker and
"The design of the Isolate Bait System comes directly from
customer requests, who wanted to maintain the efficacy
of ContraPest, but make the deployment and servicing quicker
and easier. The design combines the tank and tray into one unit,
and deployment is a simple placement and peel off seal. This
simplicity and convenience will expand our addressable market to a
broader array of customers and accelerate revenue growth as more
customers find alternatives that fit their needs better," said
Joel Fruendt, SenesTech's President and CEO.
"Concurrently, we are introducing an enhanced formulation that
will improve the product's performance in a wide variety of
environmental conditions," continued Mr. Fruendt.
"Consumers will benefit from these innovative advancements, and
we expect that these expanded product offerings will help
accelerate revenue growth," concluded Mr. Fruendt.
The ContraPest delivery options now include:
Ease of use and
Targeted for above
Ultimate T&T Bait
Larger size for
We are the experts in rat
fertility control. Our passion is to create a healthy environment
by better controlling rat pest populations. We keep an inescapable
truth in mind. Two rats and their descendants can be responsible
for the birth of up to 15,000 pups after a year. We invented
ContraPest, the only U.S. EPA registered contraceptive for male and
female rats. ContraPest fits seamlessly into all integrated pest
management programs, greatly improving the overall goal of
effective rat management. We strive for clean cities, efficient
businesses, and happy households – with a product that was designed
to be effective and sustainable without killing rats.
At SenesTech, we are committed to improving the health of the
world by humanely managing animal populations through fertility
For more information and to order, visit
Safe Harbor Statement
This press release contains
"forward-looking statements" within the meaning of federal
securities laws, and we intend that such forward-looking statements
be subject to the safe harbor created thereby. Such forward-looking
statements include, among others, our expectation that the enhanced
formulation of ContraPest will provide improved performance of the
fertility control bait in the field; our belief that the new design
of the Isolate Bait System, along with an enhanced formulation,
ensures improved performance in the field and higher acceptance by
rats, providing superior results; our belief that the enhanced
formulation of ContraPest will improve the product's performance in
a wide variety of environmental conditions; our belief that rats
may prefer the new delivery system; and our belief that our
expanded product offerings will help accelerate revenue growth as
customers find alternatives that fit their needs better.
Forward-looking statements may describe future expectations, plans,
results or strategies and are often, but not always, made through
the use of words such as "believe," "may," "future," "plan,"
"will," "should," "expect," "anticipate," "eventually," "project,"
"estimate," "continuing," "intend" and similar words or phrases.
You are cautioned that such statements are subject to risks,
uncertainties and other factors that could cause actual results to
differ materially from those reflected by such forward-looking
statements. Such factors include, among others, the impacts and
implications of the COVID-19 pandemic, the successful
commercialization of our products, market acceptance of our
products, regulatory approval and regulation of our products and
other factors and risks identified from time to time in our filings
with the Securities and Exchange Commission, including our Annual
Report on Form 10-K for the fiscal year ended December 31, 2022. All forward-looking statements
contained in this press release speak only as of the date on which
they were made and are based on management's assumptions and
estimates as of such date. Except as required by law, we do not
undertake any obligation to publicly update any forward-looking
statements, whether as a result of the receipt of new information,
the occurrence of future events or otherwise.
Investors: Robert Blum, Joe
Dorame, Joe Diaz, Lytham Partners, LLC,
Company: Tom Chesterman, Chief Financial Officer,
View original content to download
SOURCE SenesTech, Inc.